Tacrolimus granules
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Kidney Transplantation
Conditions
Kidney Transplantation, Heart Transplantation, Liver Transplantation
Trial Timeline
Jun 9, 2011 โ Feb 3, 2015
NCT ID
NCT01371331About Tacrolimus granules
Tacrolimus granules is a approved stage product being developed by Astellas Pharma for Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT01371331. Target conditions include Kidney Transplantation, Heart Transplantation, Liver Transplantation.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01371331 | Approved | Completed |
Competing Products
20 competing products in Kidney Transplantation